Get this analysis on your stocks daily!

Amyris, Inc., a renewable products company, engages in the provision of various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. The company builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as a moisturizing ingredient in cosmetics and other personal care products. The company also provides Biofene for various polymer applications; and for the development of ingredients for the fabric and home care, and the personal care markets. In addition, it is involved in the sale of ethanol and ethanol-blended gasoline to wholesale customers through a network of terminals primarily in the Eastern Unites States; and the development, production, and commercialization of renewable base oils for the automotive, industrial, and commercial lubricants markets, as well as offers natural oils and aroma chemicals for the flavors and fragrances market. It has a strategic partnership with Total for the development of renewable diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.